Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy IN8bio stock

Learn how to easily invest in IN8bio stock.

In8bio Inc is a biotechnology business based in the US. IN8bio shares (INAB) are listed on the NASDAQ and all prices are listed in US Dollars. IN8bio employs 19 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in IN8bio

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – INAB – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

IN8bio stock price (NASDAQ: INAB)

Use our graph to track the performance of INAB stocks over time.

IN8bio shares at a glance

Information last updated 2022-09-25.
Latest market close$1.78
52-week range$1.75 - $9.42
50-day moving average $2.27
200-day moving average $3.19
Wall St. target price$11.67
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.29

Buy IN8bio shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 8 of 8
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Ally Invest Self-Directed Trading
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$100
when you deposit or transfer $10,000–$24,900
500+ commission-free ETFs, some of the industry's lowest fees plus a cash bonus up to $3,000.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy IN8bio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

IN8bio price performance over time

Historical closes compared with the close of $1.78 from 2022-09-26

1 week (2022-09-20) -23.28%
1 month (2022-08-26) -9.18%
3 months (2022-06-28) -24.99%
6 months (2022-03-28) -45.23%
1 year (2021-09-28) -75.68%
2 years (2020-09-24) N/A
3 years (2019-09-24) N/A
5 years (2017-09-24) N/A

IN8bio financials

Gross profit TTM $0
Return on assets TTM -58.09%
Return on equity TTM -112.18%
Profit margin 0%
Book value $1.41
Market capitalisation $48.8 million

TTM: trailing 12 months

IN8bio share dividends

We're not expecting IN8bio to pay a dividend over the next 12 months.

You may also wish to consider:

IN8bio overview

IN8bio, Inc. , a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of glioblastoma and solid tumors; and INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with acute leukemia undergoing hematopoietic stem cell transplantation. It also develops INB-400 and INB-300 that is in preclinical Phase for treatment of various solid tumor cancers. The company was formerly known as Incysus Therapeutics, Inc. and changed its name to IN8bio, Inc. in August 2020.

Frequently asked questions

What percentage of IN8bio is owned by insiders or institutions?
Currently 25.748% of IN8bio shares are held by insiders and 14.096% by institutions.
How many people work for IN8bio?
Latest data suggests 19 work at IN8bio.
When does the fiscal year end for IN8bio?
IN8bio's fiscal year ends in December.
Where is IN8bio based?
IN8bio's address is: 350 5th Avenue, New York, NY, United States, 10118
What is IN8bio's ISIN number?
IN8bio's international securities identification number is: US45674E1091

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site